DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Sodium oxybate

Sodium oxybate

  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al

  • List of Union Reference Dates A

    List of Union Reference Dates A

  • 211230Orig1s000 211230Orig2s000

    211230Orig1s000 211230Orig2s000

  • Misuse of Drugs Act 1975

    Misuse of Drugs Act 1975

  • Nonpeptide Orexin Type-2 Receptor Agonist Ameliorates Narcolepsy-Cataplexy Symptoms in Mouse Models

    Nonpeptide Orexin Type-2 Receptor Agonist Ameliorates Narcolepsy-Cataplexy Symptoms in Mouse Models

  • Les Perspectives Dans La Prise En Charge Thérapeutique De L'alcoolo

    Les Perspectives Dans La Prise En Charge Thérapeutique De L'alcoolo

  • Xyrem (Sodium Oxybate) Is a CNS Depressant

    Xyrem (Sodium Oxybate) Is a CNS Depressant

  • Sodium Oxybate (Xyrem®) Armodafinil (Nuvigil®) Solriamfetol (Sunosi®) Approval December 1998 July 2002 June 2007 March 2019 Cephalon, Inc

    Sodium Oxybate (Xyrem®) Armodafinil (Nuvigil®) Solriamfetol (Sunosi®) Approval December 1998 July 2002 June 2007 March 2019 Cephalon, Inc

  • (12) Patent Application Publication (10) Pub. No.: US 2011/0159073 A1 De Juan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2011/0159073 A1 De Juan Et Al

  • Sodium Oxybate) Policy Number: C3925-A

    Sodium Oxybate) Policy Number: C3925-A

  • Label for SODIUM OXYBATE Oral Solution

    Label for SODIUM OXYBATE Oral Solution

  • Misuse of Drugs Act 1975

    Misuse of Drugs Act 1975

  • Do You Know... GHB

    Do You Know... GHB

  • Gamma-Hydroxybutyric Acid (GHB) Critical Review Report

    Gamma-Hydroxybutyric Acid (GHB) Critical Review Report

  • Xyrem, Effects on Sleepiness, Attention and Cognition Were Investigated in the Pharmacokinetic Interaction Studies Conducted in Healthy Volunteers

    Xyrem, Effects on Sleepiness, Attention and Cognition Were Investigated in the Pharmacokinetic Interaction Studies Conducted in Healthy Volunteers

  • Psychosis in the Context of Sodium Oxybate Therapy Jody Langford, M.D.; William L

    Psychosis in the Context of Sodium Oxybate Therapy Jody Langford, M.D.; William L

  • Sleep Medicine a Special Report June 2021

    Sleep Medicine a Special Report June 2021

  • Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide

    Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide

Top View
  • Council of Europe Committee of Ministers (Partial
  • Product Monograph Including Patient Medication Information
  • SODIUM OXYBATE Oral Solution (Xyrem®)
  • A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
  • Misuse of Drugs Act 1975
  • Xyrem (Sodium Oxybate/GHB)
  • Sodium Oxybate) Original Effective Date: 10/30/2013
  • Atc Index 2010
  • Oxybate Prior Authorization with Quantity Limit Program Summary
  • Relative Abuse Liability of GHB in Humans
  • Quarterwatch: Data from 2013 Quarters 2 & 3
  • A Comprehensive Review of MDMA and GHB: Two Common Club Drugs
  • Sodium Oxybate (Xyrem® [Sodium Oxybate], Xywav™ [Calcium, Magnesium, Potassium, and Sodium Applicable Oxybates])
  • Xyrem, INN-Sodium Oxybate
  • XYREM (Sodium Oxybate) RATIONALE for INCLUSION IN
  • California 3 Tier Drug List
  • Center for Drug Information and Pharmacy Practice1, ABDA
  • DRUGS of ABUSE / Uses and Effects


© 2024 Docslib.org    Feedback